Univercells Receives $12 Million Grant to Develop Breakthrough Vaccine Manufacturing Platform

We are extremely honored to have been awarded a $12 Million grant by the Bill & Melinda Gates Foundation to develop a breakthrough vaccine manufacturing platform. All along we had made it our mission to lower costs and increase vaccine availability and affordability in developing countries, and now we are making it possible. We’re looking forward to collaborate with our consortium partners Batavia Biosciences and Natrix Separations.
Download the Press Release EN / FR / NL